ACHIEVE LIFE SCIENCES, INC. - 8-K Filing

Achieve Life Sciences appointed Jeff Farrow and Reid Waldman, M.D., as directors on May 29, 2026. Mr. Farrow was named Chair of the Audit Committee and a member of the Nominating and Governance Committee; Dr. Waldman became Chair of the Compensation Committee and a member of the Commercial Committee. Each received stock options for 47,250 shares vesting over three years and pro-rated annual retainers under the company's non-employee director compensation program. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)

SEC EDGAR ·

Tickers: $ACHV

Read the full article at SEC EDGAR

More Regulatory news